BABS-360-RIDE-logo
Eric Hurnyak and Barbara Johnson
Barbara “Babs” Johnson’s journey with grade 4 glioblastoma, which is an extremely aggressive form of brain cancer, began just after her 71st birthday, introducing her and her only son, Eric Hurnyak, to a whirlwind of palliative care and relentless medical battles. Despite the gravity of her diagnosis, Babs approached her fight with unwavering determination, diving into research on the disease and clinical trials while maintaining her trademark positivity. As her illness progressed, Eric, spurred by her resilience, turned to endurance cycling for solace and strength, finding a way to honor his mother’s wishes through the Babs 360 Ride.

 

The Babs 360 Ride is a testament to Babs’ spirit, covering 360 miles along the Erie Canalway Trail from Buffalo to Albany. This arduous journey symbolizes the ongoing fight against glioblastoma and aims to raise awareness and vital funds for the Glioblastoma Research Organization. Inspired by the organization’s mission and the story of its founder, Amber Barbach, who also navigated the challenges of a parent’s glioblastoma diagnosis, this ride honors Babs’ legacy by continuing her quest for hope and progress in the face of adversity.

 

Eric Hurnyak will begin the ride July 15th 2024 and end on July 21st 2024.  

PRESS RELEASE

 

Endurance Cyclist Eric Hurnyak to Embark on 360-Mile Ride to Raise Funds for Glioblastoma Research

Sound Beach, New York, 05.14.2024 – Eric Hurnyak, an endurance cyclist and advocate for glioblastoma research, is gearing up to undertake the Babs 360 Ride, a 360-mile cycling journey along the Erie Canalway Trail from Buffalo to Albany. The ride, scheduled from July 15th to July 21st, is dedicated to raising awareness and funds for The Glioblastoma Research Organization.

The Babs 360 Ride is inspired by Eric’s mother, Barbara “Babs” Johnson, who has been battling grade 4 glioblastoma, an aggressive form of brain cancer, since just after her 71st birthday. Despite the challenges she faces, Babs has shown remarkable resilience and positivity, inspiring Eric and countless others.

“This ride is a tribute to my mother’s strength and courage in the face of glioblastoma,” says Eric Hurnyak. “I want to do everything I can to raise funds for research and support other families affected by this devastating disease.”

Glioblastoma is one of the most aggressive forms of brain cancer, with a low survival rate and limited treatment options. The Glioblastoma Research Organization is dedicated to funding research initiatives aimed at finding better treatments and ultimately a cure for glioblastoma.

“The Babs 360 Ride is not just about covering 360 miles on a bike; it’s about spreading hope and raising awareness for glioblastoma research,” adds Hurnyak.

The journey will begin on July 15th, starting in Buffalo, and will conclude on July 21st in Albany. Along the way, Eric will document his ride and share updates on his progress through social media channels.

Supporters can join Eric in his mission by making a donation through his fundraising page. Every contribution will directly support glioblastoma research and help make a difference in the lives of patients and families affected by this disease.

To learn more about Eric’s journey and to make a donation, click here.

For media inquiries or interview requests, please contact Eric Hurnyak at 631-428-7876 or soundbeachsigns@gmail.com

About Eric Hurnyak:

Eric Hurnyak is an endurance cyclist and advocate for glioblastoma research. Inspired by his mother’s battle with grade 4 glioblastoma, Eric is dedicated to raising awareness and funds for research initiatives aimed at finding better treatments and ultimately a cure for this devastating disease.

About The Glioblastoma Research Organization:

The Glioblastoma Research Organization is dedicated to funding research initiatives aimed at finding better treatments and ultimately a cure for glioblastoma, an aggressive form of brain cancer with a low survival rate. Through fundraising efforts and community support, the organization aims to improve outcomes for patients and families affected by this disease.